Axon Laboratories Private Limited
About Axon Laboratories Private Limited
Data last updated:
Axon Laboratories Private Limited is a private limited company based in Hoshiarpur, Punjab, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 February 1997 and has been in existence for over 29 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24230PB1997PTC019447. Its GSTIN is 03AABCA1425F1ZI (Punjab).
The company has an authorised share capital of ₹60 Lakh and a paid-up capital of ₹40 Lakh. It is led by directors Somanshu Sood (Managing Director) and Tanya Sood.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Heera Colony Hoshiarpur, Punjab, India – 146001.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.68 Cr, a growth of 58% compared to the previous year. For the same year it recorded a net profit of ₹11.08 Lakh (net margin 6.6%) and EBITDA of ₹27.73 Lakh (EBITDA margin 16.5%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years.
As per MCA filings, the company has open charges of ₹40.5 Lakh and satisfied charges of ₹1.02 Cr on record. Court records list 2 cases involving the company, including 1 filed by the company; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressHeera Colony Hoshiarpur, Punjab, India – 146001
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Axon Laboratories Private Limited
The main business activity of Axon Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Axon Laboratories Private Limited FY 2025 filings available
Axon Laboratories Private Limited reported revenue of ₹1.68 Cr (up 58% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Axon Laboratories Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 21% over three years, including 58% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Axon Laboratories Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹27.73 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹11.08 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Axon Laboratories Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 6.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Axon Laboratories are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Axon Laboratories Private Limited
Axon Laboratories has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Somanshu Sood | Managing Director | 23 Sep 2020 | 6 Years 0 Months | Current |
| Tanya Sood | Director | 31 Jan 2021 | 5 Years 8 Months | Current |
Peer Comparison of Axon Laboratories Private Limited
Axon Laboratories Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Lifespan Biotech Private Limited | ₹1.7 Cr (FY 2019) | •••• | •••• | -86.0% | •••• | Raisen, Madhya Pradesh, India |
| Graseth Medicare Private Limited | ₹1.7 Cr (FY 2024) | •••• | •••• | -8.0% | •••• | Hyderabad, Telangana, India |
| Infocus Remedies Private Limited | ₹1.69 Cr (FY 2025) | •••• | •••• | -27.0% | •••• | Ahmedabad, Gujarat, India |
| Ayyans Sparklers Private Limited | ₹1.69 Cr (FY 2024) | •••• | •••• | 5.0% | •••• | Kamarajar Dt, Tamil Nadu, India |
| Ms Suraj Pharmaceuticals (India) Private Limited | ₹1.68 Cr (FY 2024) | •••• | •••• | -2.0% | •••• | Patna, Bihar, India |
| Axon Laboratories Private Limited this company | ₹1.68 Cr (FY 2024) | •••• | •••• | 58.0% | •••• | Hoshiarpur, Punjab, India |
| Aubade Healthcare Private Limited | ₹1.68 Cr (FY 2024) | •••• | •••• | 46.0% | •••• | New Delhi, Delhi, India |
| Yogi International Private Limited | ₹1.68 Cr (FY 2025) | •••• | •••• | 42.0% | •••• | Ahmedabad, Gujarat, India |
| Centriexpert Engineers Private Limited | ₹1.68 Cr (FY 2024) | •••• | •••• | -38.0% | •••• | Pune, Maharashtra, India |
| SJP Reality Ventures Private Limited | ₹1.67 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Gonda, Uttar Pradesh, India |
| Promed Laboratories Private Limited | ₹1.67 Cr (FY 2025) | •••• | •••• | 671.0% | •••• | Indore, Madhya Pradesh, India |
Peers are the five companies nearest above and the five nearest below Axon Laboratories by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Axon Laboratories Private Limited
Axon Laboratories Private Limited is audited by D. SHARMA &CO. for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| D. SHARMA &CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Axon Laboratories Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Axon Laboratories Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Jun 2000 | Oriental Bank of Commerce | ₹5.5 Lakh | Open |
| 28 Feb 2000 | Oriental Bank of Commerce | ₹7.5 Lakh | Open |
| 28 Feb 2000 | Oriental Bank of Commerce | ₹7.5 Lakh | Open |
| 16 Jan 1999 | Oriental Bank of Commerce | ₹10 Lakh | Open |
| 16 Jan 1999 | Oriental Bank of Commerce | ₹10 Lakh | Open |
Total charge records: 8 View all charges
Legal Cases of Axon Laboratories Private Limited
Axon Laboratories Private Limited has 2 court cases on record: 1 filed by Axon Laboratories, 1 where it is another party. All cases are pending. Status as checked between 30 Sep 2026 and 01 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 1 |
| District courts | 1 | 0 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hoshiarpur, Punjab | Cheque dishonour complaint | Filed by the company against Shree Gobind Nathjee Pharma | Pending |
| High Court of Punjab and Haryana | Writ petition | Company is another party | Pending |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Axon Laboratories Private Limited
Employment history and EPFO contributions of people linked to Axon Laboratories.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Axon Laboratories Private Limited
Axon Laboratories Private Limited has 9 board changes on record since 2011: 2 appointments and 7 cessations. The latest: Tanya Sood ceased to be Additional Director on 30 Sep 2021.
15 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Axon Laboratories Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Axon Laboratories Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Axon Laboratories Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Axon Laboratories Private Limited
Axon Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AABCA1425F1ZI | Punjab | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Axon Laboratories Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Axon Laboratories Private Limited
Axon Laboratories is an active private limited company based in Hoshiarpur, Punjab, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 February 1997 (29+ years old) and is registered under CIN U24230PB1997PTC019447.
Axon Laboratories reported revenue of ₹1.68 Cr for FY 2024 (up 58% YoY).
Axon Laboratories has 2 current directors:
- Somanshu Sood - Managing Director
- Tanya Sood - Director
Axon Laboratories reported a net profit of ₹11.08 Lakh (net margin 6.6%) and EBITDA of ₹27.73 Lakh (EBITDA margin 16.5%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Axon Laboratories is 21% over three years. In the latest year (FY 2024) revenue rose 58%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Axon Laboratories is 03AABCA1425F1ZI, registered in Punjab.
The CIN (Corporate Identification Number) of Axon Laboratories is U24230PB1997PTC019447. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Axon Laboratories has 2 court cases on record: 1 filed by the company. 2 are pending. Most are in the high courts.
Axon Laboratories was incorporated on 13 February 1997, making it 29+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Axon Laboratories by revenue are Lifespan Biotech Private Limited, Graseth Medicare Private Limited, Infocus Remedies Private Limited, Ayyans Sparklers Private Limited, Ms Suraj Pharmaceuticals (India) Private Limited and 5 more, all in the Pharma industry (Formulations).
Tanya Sood ceased to be Additional Director on 30 Sep 2021. Anil Sood ceased to be Managing Director on 31 Jan 2021. Tanya Sood was appointed as Director on 31 Jan 2021. Axon Laboratories has 9 board changes on record in total.